Published in Hepatitis Weekly, August 21st, 2006
"The aim of this study was to determine whether IGF2 polymorphisms are associated with the clearance of HBV infection and the risk of HCC. A total of 1095 Korean subjects were prospectively enrolled in this case-control study," wrote Y.J. Kim and colleagues, Seoul National University.
"The rates of IGF2 polymorphisms were determined in each group. The IGF2 + 820E allele (IGF2 + 820G/G) and the IGF2 + 6815A/A genotype were strongly associated with the resolution of HBV infection (OR=.62-.73; p=.001-.03 and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.